MedTrace Logo

THIODERM ELATE for Augmentation of Very Thin, Thin, and Moderately Thick Lips

NCT06135337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-12-13

No results posted yet for this study

Summary

This mono-center clinical investigation is intended to assess the safety and effectiveness of THIODERM ELATE for augmentation of very thin and thin lips in comparison with Juvéderm® Ultra 3.

Conditions

  • Lip Abnormality

Interventions

DEVICE

Thioderm Elate

Test Device

DEVICE

Juvéderm Ultra 3

Active Comparator Device

Sponsors & Collaborators

  • Proinnovera GmbH

    collaborator INDUSTRY

  • Croma-Pharma GmbH

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-01-10
Completion
2024-09-09

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06135337 on ClinicalTrials.gov